For patients with heart failure or chronic kidney disease, SGLT2 inhibitors are generally preferred first, with GLP-1 agonists considered when SGLT2 inhibitors are contraindicated or not tolerated
Never trust a supplier that doesnt submit to third-party testing
KN content was significantly suppressed in Rib + amlodipine (31%), Rib + aminoguanidine (25%), and Rib + NAC (15%) compared to Rib
Levity aims to offer accessible weight loss solutions that integrate clinical care and convenience
For an individual who has lost a significant amount of weight, skin laxity can sometimes make the stomach or thigh feel less firm for an injection
March 10, 2025: Eli Lilly Cuts Cost of Zepbound Through Direct-to-Consumer Pharmacy In a move to make Zepbound available to more patients, Eli Lilly has created a direct-to-consumer pharmacy where patients can buy the weight-loss drug at a reduced price if they pay with cash and do not use insurance